Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-1286]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Noramco has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to 
                        **SUPPLEMENTARY INFORMATION**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before January 8, 2024. Such persons may also file a written request for a hearing on the application on or before January 8, 2024.
 ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to 
                        *https://www.regulations.gov*
                         and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on 
                        *https://www.regulations.gov.*
                         If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on October 04, 2023, Noramco, 500 Swedes Landing Road, Wilmington, Delaware 19801-4417, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled
                             substance
Drug
                             code
ScheduleGamma Hydroxybutyric Acid
2010
IMarihuana
7360
ITetrahydrocannabinols
7370
ICodeine-N-oxide
9053
IDihydromorphine
9145
IHydromorphinol
9301
IMorphine-N-oxide
9307
IAmphetamine
1100
IILisdexamfetamine
1205
IIMethylphenidate
1724
II( print page 77109)Nabilone
7379
IIPhenylacetone
8501
IICodeine
9050
IIDihydrocodeine
9120
IIOxycodone
9143
IIHydromorphone
9150
IIHydrocodone
9193
IIMorphine
9300
IIOripavine
9330
IIThebaine
9333
IIOpium extracts
9610
IIOpium fluid extract
9620
IIOpium, tincture
9630
IIOpium, powdered
9639
IIOpium, granulated
9640
IIOxymorphone
9652
IINoroxymorphone
9668
IITapentadol
9780
II
 The company plans to bulk manufacture the listed controlled substances as an Active Pharmaceutical Ingredient for supply to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Claude Redd, Acting Deputy Assistant Administrator.


[FR Doc. 2023-24613 Filed 11-7-23; 8:45 am] BILLING CODE P